Merck recently added two members to its Management Committee: Willie A. Deese, president, Merck Manufacturing Division; and J. Chris Scalet, senior vice president, Global Process and Services, and chief information officer. Merck also announced changes in the responsibilities of several other Management Committee members to strengthen the Company's ability to focus on the critical needs of our business.
From left to right: (seated) Per Wold-Olsen, 58, president, Human Health-Intercontinental; Judy C. Lewent, 57, executive vice president and chief financial officer; (seated) Bradley T. Sheares, Ph.D., 49, president, U.S. Human Health; Adel A.F. Mahmoud, M.D., Ph.D., 64, chief medical advisor, Vaccines and Infectious Diseases; Willie A. Deese, 50; (seated) Richard T. Clark, 59, chief executive officer and president; Margaret G. McGlynn, 46, president, Merck Vaccine Division; (seated) Peter S. Kim, Ph.D., 47, president, Merck Research Laboratories; Kenneth C. Frazier, 51, senior vice president and general counsel; (seated) David W. Anstice, 57, president, Asia Pacific Human Health; J. Chris Scalet, 47; Marcia J. Avedon, Ph.D., 44, senior vice president, Human Resources.
